Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
PHASE4CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
January 31, 2013
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Conditions
Diabetic RetinopathyGlaucoma, Neovascular
Interventions
DRUG
ranibizumab
All Listed Sponsors
collaborator
Ningbo University
OTHER
lead
Ruijin Hospital
OTHER
NCT02647515 - Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma | Biotech Hunter | Biotech Hunter